J Kienast

1.4k total citations
22 papers, 1.0k citations indexed

About

J Kienast is a scholar working on Epidemiology, Hematology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, J Kienast has authored 22 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 7 papers in Hematology and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in J Kienast's work include Sepsis Diagnosis and Treatment (5 papers), Venous Thromboembolism Diagnosis and Management (5 papers) and Neutropenia and Cancer Infections (4 papers). J Kienast is often cited by papers focused on Sepsis Diagnosis and Treatment (5 papers), Venous Thromboembolism Diagnosis and Management (5 papers) and Neutropenia and Cancer Infections (4 papers). J Kienast collaborates with scholars based in Germany, United Kingdom and United States. J Kienast's co-authors include Gregor Schmitz, Helmut Ostermann, Richard Strauß, B L Warren, Christian J. Wiedermann, Johannes Hoffmann, Steven M. Opal, Herwig Ostermann, T.C. Stevenson Keller and PM Mannucci and has published in prestigious journals such as Blood, Journal of the American College of Cardiology and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

J Kienast

22 papers receiving 956 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Kienast Germany 10 475 375 224 223 200 22 1.0k
Yoshihiro Wakita Japan 17 550 1.2× 282 0.8× 205 0.9× 287 1.3× 195 1.0× 29 1.0k
E.A.R. Knot Netherlands 16 255 0.5× 248 0.7× 357 1.6× 118 0.5× 85 0.4× 35 868
Philip M. Blatt United States 17 714 1.5× 153 0.4× 185 0.8× 167 0.7× 252 1.3× 38 1.3k
Akio Kidokoro Japan 14 178 0.4× 352 0.9× 212 0.9× 90 0.4× 96 0.5× 49 727
Chika Uotani Japan 18 363 0.8× 117 0.3× 156 0.7× 188 0.8× 201 1.0× 45 749
Anne Riddell United Kingdom 26 871 1.8× 261 0.7× 342 1.5× 189 0.8× 242 1.2× 68 1.7k
Yoshinobu Seki Japan 14 371 0.8× 241 0.6× 108 0.5× 191 0.9× 107 0.5× 53 756
René van Oerle Netherlands 17 431 0.9× 98 0.3× 144 0.6× 298 1.3× 236 1.2× 31 936
Emmanuelle de Raucourt France 17 324 0.7× 471 1.3× 328 1.5× 150 0.7× 105 0.5× 54 1.3k
G. Huhle Germany 14 159 0.3× 275 0.7× 304 1.4× 140 0.6× 320 1.6× 31 825

Countries citing papers authored by J Kienast

Since Specialization
Citations

This map shows the geographic impact of J Kienast's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Kienast with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Kienast more than expected).

Fields of papers citing papers by J Kienast

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Kienast. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Kienast. The network helps show where J Kienast may publish in the future.

Co-authorship network of co-authors of J Kienast

This figure shows the co-authorship network connecting the top 25 collaborators of J Kienast. A scholar is included among the top collaborators of J Kienast based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Kienast. J Kienast is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Meister, Tobias, Guido Bisping, Matthias Stelljes, et al.. (2008). Intestinal graft-versus-host-disease staging by video capsule endoscopy. Endoscopy. 40(S 02). E144–E144. 4 indexed citations
2.
Kienast, J, Christian J. Wiedermann, Johannes Hoffmann, et al.. (2005). Treatment effects of high‐dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation. Journal of Thrombosis and Haemostasis. 4(1). 90–97. 294 indexed citations
3.
Steins, Martin, Ralf Bieker, Teresa Padró, et al.. (2003). Thalidomide for the Treatment of Acute Myeloid Leukemia. Leukemia & lymphoma. 44(9). 1489–1493. 7 indexed citations
4.
Einsele, Hermann, Hartmut Bertz, J. Beyer, et al.. (2001). Epidemiologie und interventionelle Therapiestrategien infektiöser Komplikationen nach allogener Stammzelltransplantation. DMW - Deutsche Medizinische Wochenschrift. 126(45). 1278–1284. 5 indexed citations
5.
Harenberg, Job, K Breddin, Fritz Heinrich, et al.. (1997). Treatment of Deep Vein Thrombosis with Low-Molecular-Weight Heparins: A Consensus Statement of the Gesellschaft für Thrombose-und Hämostaseforschung (GTH). Seminars in Thrombosis and Hemostasis. 23(1). 91–96. 5 indexed citations
6.
Kiehl, Michael, et al.. (1996). Volume-controlled versus biphasic positive airway pressure ventilation in leukopenic patients with severe respiratory failure. Critical Care Medicine. 24(5). 780–784. 8 indexed citations
7.
Sindermann, Jürgen, et al.. (1996). Severe Hepatobiliary Complication in a Patient with Acute Promyelocytic Leukemia Treated with all-Trans Retinoic Acid. Acta Oncologica. 35(4). 499–501. 3 indexed citations
8.
Mannucci, PM, et al.. (1996). Factor VIIa and antithrombin III activity during severe sepsis and septic shock in neutropenic patients. Blood. 88(3). 881–886. 158 indexed citations
9.
Mannucci, PM, et al.. (1996). Factor VIIa and antithrombin III activity during severe sepsis and septic shock in neutropenic patients. Blood. 88(3). 881–886. 11 indexed citations
10.
Padró, Teresa, J.J. Emeis, Martin Steins, Kurt Werner Schmid, & J Kienast. (1995). Quantification of Plasminogen Activators and Their Inhibitors in the Aortic Vessel Wall in Relation to the Presence and Severity of Atherosclerotic Disease. Arteriosclerosis Thrombosis and Vascular Biology. 15(7). 893–902. 101 indexed citations
11.
Mesters, Rolf M., et al.. (1995). Markers of coagulation activation for evaluation of the antithrombotic efficacy of heparin. Blood Coagulation & Fibrinolysis. 6(7). 665–671. 9 indexed citations
12.
Kienast, J. (1995). Coagulation and Fibrinolysis. Cerebrovascular Diseases. 5(2). 89–92. 7 indexed citations
13.
Close, Philippe, J. Bichler, Roger Kerry, et al.. (1994). Weak allergenicity of recombinant hirudin CGP 39393 (REVASC) in immunocompetent volunteers. The European Hirudin in Thrombosis Group (HIT Group).. PubMed. 5(11). 943–9. 33 indexed citations
14.
Ostermann, Helmut, Markus Rothenburger, Rolf M. Mesters, J. van de Loo, & J Kienast. (1994). Cytokine response to infection in patients with acute myelogenous leukaemia following intensive chemotherapy. British Journal of Haematology. 88(2). 332–337. 41 indexed citations
15.
Verstraete, Marc, Michael T. Nurmohamed, J Kienast, et al.. (1993). Biologic effects of recombinant hirudin (CGP 39393) in human volunteers. Journal of the American College of Cardiology. 22(4). 1080–1088. 54 indexed citations
16.
Bolíbar, Ignasi, J Kienast, Simon G. Thompson, et al.. (1993). Relation of fibronogen to presence and severity of coronary artery disease is independent of other coexisting heart disease. American Heart Journal. 125(6). 1601–1605. 30 indexed citations
17.
Pyke, Stephen, et al.. (1993). Variability over Time of Haemostatic and Other Cardiovascular Risk Factors in Patients Suffering from Angina Pectoris. Thrombosis and Haemostasis. 70(5). 743–746. 6 indexed citations
18.
Loo, J. van de, et al.. (1991). Hämostasefaktoren und koronare Herzkrankheit. Hämostaseologie. 11(4). 172–188. 3 indexed citations
19.
Kienast, J & Gregor Schmitz. (1990). Flow cytometric analysis of thiazole orange uptake by platelets: a diagnostic aid in the evaluation of thrombocytopenic disorders. Blood. 75(1). 116–121. 210 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoshihiro Wakita Breakdown of academic impact, for papers by E.A.R. Knot Breakdown of academic impact, for papers by Philip M. Blatt Breakdown of academic impact, for papers by Akio Kidokoro Breakdown of academic impact, for papers by Chika Uotani Breakdown of academic impact, for papers by Anne Riddell Breakdown of academic impact, for papers by Yoshinobu Seki Breakdown of academic impact, for papers by René van Oerle Breakdown of academic impact, for papers by Emmanuelle de Raucourt Breakdown of academic impact, for papers by G. Huhle
Rankless by CCL
2026